The Relationship of Cardiovascular Disease to Hyperglycemia

Ostrander Jr., Leon D.; Francis Jr., Thomas; Hayner, Norman S.; Kjelsberg, Marcus O.; Epstein, Frederick H.
June 1965
Annals of Internal Medicine;Jun65, Vol. 62 Issue 6, p1188
Academic Journal
Discusses studies on the relationship of cardiovascular disease to hyperglycemia. Percentage of diabetics who died of cardiovascular disease in 1957; Prevalence and severity of coronary atherosclerosis among hospitalized diabetics; Association between vascular disease and abnormalities of glucose metabolism.


Related Articles

  • Cardiovascular Importance of Hyperglycemia and Hypoglycemia. TKÁČ, IVAN // Diabetes Care;Aug2013 Supplement, Vol. 36 Issue S2, pS267 

    The article examines evidence-based research papers related to hyperglycemia and hypoglycemia as factors conributing to the development of cardiovascular events in patients with type 2 diabetes. It discusses the relationship of hyperglycemia to cardiovascular disease based on analysis of...

  • Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Bakker, Wineke; Eringa, Etto C,; Sipkema, Pieter; van Hinsbergh, Victor W. M. // Cell & Tissue Research;Dec2008, Vol. 335 Issue 1, p165 

    Endothelial dysfunction comprises a number of functional alterations in the vascular endothelium that are associated with diabetes and cardiovascular disease, including changes in vasoregulation, enhanced generation of reactive oxygen intermediates, inflammatory activation, and altered barrier...

  • Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort. Simmons, Rebecca K.; Coleman, Ruth L.; Price, Hermione C.; Holman, Rury R.; Khaw, Kay-Tee; Wareham, Nicholas J.; Griffin, Simon J. // Diabetes Care;Apr2009, Vol. 32 Issue 4, p708 

    OBJECTIVE -- The purpose of this study was to examine the performance of the UK Prospective Diabetes Study (UKPDS) Risk Engine (version 3) and the Framingham risk equations (2008) in estimating cardiovascular disease (CVD) incidence in three populations: 1) individuals with known diabetes; 2)...

  • Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Okon, Elena B.; Chung, Ada W.Y.; Zhang, Hongbin; Laher, Ismail; van Breemen, Cornelis // Canadian Journal of Physiology & Pharmacology;May2007, Vol. 85 Issue 5, p562 

    Diabetes mellitus impairs endothelial function, which can be considered as the hallmark in the development of cardiovascular diseases. Hyperglycemia, hyperinsulinemia, and hyperlipidemia are believed to contribute to endothelial dysfunction. In the present study, we investigated the possible...

  • Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects. Juutilainen, Auni; Lehto, Seppo; Rönnemaa, Tapani; Pyörälä, Kalevi; Laakso, Markku // Diabetes Care;Apr2008, Vol. 31 Issue 4, p714 

    OBJECTIVE -- To compare the risk of cardiovascular disease (CVD) death and the impact of hyperglycemia on the risk of CVD mortality associated with type 1 diabetes to that associated with type 2 diabetes. RESEARCH DESIGN AND METHODS -- The study comprised 173 participants with type 1 diabetes,...

  • Postprandial Hyperglycemia and Cardiovascular Disease. Ceriello, Antonio // Diabetes Care;Mar2009, Vol. 32 Issue 3, p521 

    The author discusses whether the Hyperglycemia and its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (HEART2D) study can resolve the debate about the association of postprandial hyperglycemia with cardiovascular disease. He notes...

  • Hyperglycemia and Cardiovascular Disease in Critically III Patients with Diabetes: Trends from 2002-05 vs. 1996-97. Falciglia, Mercedes; Freyberg, Ron W.; Almenoff, Peter L.; D'Alessio, David A.; Render, Marta L. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA178 

    Numerous studies have shown that hyperglycemia is common in critically ill patients and that it increases mortality risk, particularly in those with cardiovascular disease (CVD). Intervention trials of glucose lowering with intensive insulin therapy in patients hospitalized with CVD have...

  • Insulin-Sensitizing Antihyperglycemic Drugs and Mortality After Acute Myocardial Infarction. Inzucchi, Silvio E.; Masoudi, Frederick A.; Wang, Yongfei; Kosiborod, Mikhail; Foody, Joanne M.; Setaro, John F.; Havranek, Edward P.; Krumholz, Harlan M. // Diabetes Care;Jul2005, Vol. 28 Issue 7, p1680 

    OBJECTIVE -- Thiazolidinediones (TZDs) and metformin are insulin-sensitizing antihyperglycemic agents with reported benefits on atherosclerosis. Despite extensive use in patients with diabetes and cardiovascular disease, there is a paucity of outcomes data with metformin and none yet with TZDs....

  • No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes. Wenzel, Sibylle; Soltanpour, Golozar; Schlüter, Klaus-Dieter // Pflugers Archiv European Journal of Physiology;Nov2005, Vol. 451 Issue 2, p328 

    Besides the classical cardiovascular diseases, high levels of blood glucose directly interfere with cardiomyocytes. The mechanisms responsible for this have not yet been explored in detail. This study aims to determine if hyperglycaemia has any impact on prominent signalling molecules and on the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics